UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053259
Receipt number R000060539
Scientific Title Artificial Intelligence-based automated ECHOcardiographic measurements and the workflow of sonographers: Randomized Control Trial (AI-ECHO RCT)
Date of disclosure of the study information 2024/01/10
Last modified on 2024/07/03 10:38:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Artificial Intelligence-based automated ECHOcardiographic measurements and the workflow of sonographers: Randomized Control Trial (AI-ECHO RCT)

Acronym

Artificial Intelligence-based automated ECHOcardiographic measurements and the workflow of sonographers: Randomized Control Trial (AI-ECHO RCT)

Scientific Title

Artificial Intelligence-based automated ECHOcardiographic measurements and the workflow of sonographers: Randomized Control Trial (AI-ECHO RCT)

Scientific Title:Acronym

AI-ECHO RCT

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Medicine in general Cardiology Surgery in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine whether the use of AI-based automatic measurement increases the efficiency of echocardiography tests and the number of tests performed by sonographers.

Basic objectives2

Others

Basic objectives -Others

To determine whether the use of AI-based automatic measurement increases the efficiency of echocardiography tests and the number of tests performed by sonographers.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The number of echocardiographic tests performed one day and efficiency of tests.

Key secondary outcomes

Testing time per case; reporting time; changes in survey results; rate of change in measurements in final check by physician; and time required for final check by physician.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Use of AI-based automated echocardiographic measurements

Interventions/Control_2

Traditional manual measurements

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The research subjects will be those who meet all of the following and do not meet any of the exclusion criteria.
(1) Clinical sonographers who are at least 20 years of age at the time of consent, who work full-time at Juntendo University Hospital, and who have at least one year of experience in echocardiography.

Key exclusion criteria

(1) Sonographers who are deemed by the physician in charge to have difficulty participating in the study due to reasons such as impaired comprehension or mental instability
(2)Sonographers who are deemed inappropriate for the study by the attending physician.

Target sample size

8


Research contact person

Name of lead principal investigator

1st name Tohru
Middle name
Last name Minamino

Organization

Juntendo University Hospital

Division name

Department of Cardiovascular Biology and Medicine

Zip code

113-8431

Address

3-1-3 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Email

t.minamino@juntendo.ac.jp


Public contact

Name of contact person

1st name Nobuyuki
Middle name
Last name Kagiyama

Organization

Juntendo University Hospital

Division name

Department of Cardiovascular Biology and Medicine

Zip code

113-8431

Address

3-1-3 Hongo, Bunkyo-ku, Tokyo

TEL

03-3813-3111

Homepage URL


Email

kagiyaman@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)

M3 AI, Inc.


IRB Contact (For public release)

Organization

Medical Research Ethics Committee, Juntendo University

Address

3-1-3 Hongo, Bunkyo-ku, Tokyo

Tel

03-3814-5672

Email

hongo-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学医学部附属順天堂医院(東京都)


Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

8

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 06 Month 02 Day

Date of IRB

2023 Year 08 Month 30 Day

Anticipated trial start date

2024 Year 01 Month 30 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 02 Day

Last modified on

2024 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060539